BOCA RATON, FL / ACCESSWIRE / November 19, 2024 / WoundZoom is thrilled to introduce WoundZoom LIGHT, a HIPAA-compliant point ...
Owen Mumford Awarded Safety Phlebotomy and Specimen Collection Products Agreement With Premier, Inc.
MARIETTA, GA / ACCESSWIRE / November 19, 2024 / Owen Mumford has been awarded a national group purchasing agreement for Safety Phlebotomy and Specimen Collection Products with Premier, Inc. Effective ...
We all have a unique face, fingerprint, voice and signature, so why wouldn’t we have a unique response to the medicine and ...
THE001 safe and well tolerated in first two dose level, demonstrating encouraging signs of clinical activityData presented at ...
Abbott today marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony ...
Established in Milan, Italy in 2021, Napo Therapeutics is focused on expanding access to crofelemer, Jaguar's novel oral plant-based prescription drug, in Europe for orphan and/or rare diseases SAN ...
Webcast and conference call to be held be on Thursday, November 21st at 4:30 pm ET, dial in information belowNEWARK, CA / ACCESSWIRE / November 19, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" ...
With the New York cannabis market projected to surpass $5 billion by 2027, this acquisition positions CBDL for exponential revenue growth and expanded market dominance.SCOTTSDALE, AZ / ACCESSWIRE / ...
As previously communicated, the planned Phase IIa study will be conducted in two parts. Part 1 aims to establish dosage levels and safety of sevuparin through single doses in 25-30 patients with ...
TORONTO, ON / ACCESSWIRE / November 19, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) is excited to announce the incorporation of its wholly owned subsidiary, Enhanced Supplements Ltd., a ...
Company to Host a Conference Call with the PIs Presenting the Pivotal Trial Data on Wednesday, November 20 th at 2:00 PM Eastern Time - Click Here to Access IRVINE, CA / ACCESSWIRE / November 19, 2024 ...
DALLAS, TX / ACCESSWIRE / November 19, 2024 / Adnexus Biotechnologies Inc. is pleased to announce the appointment of Dr. Hiroshi Ohrui to its Scientific Advisory Board. Dr. Ohrui is a distinguished ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback